DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 226 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,047,250 | +58.8% | 1,425,000 | +38.9% | 0.38% | +68.8% |
Q2 2023 | $13,257,031 | +405.4% | 1,026,086 | +310.4% | 0.22% | +40.0% |
Q3 2016 | $2,623,000 | -28.0% | 250,000 | 0.0% | 0.16% | -28.3% |
Q2 2016 | $3,645,000 | -24.2% | 250,000 | 0.0% | 0.22% | -17.1% |
Q1 2016 | $4,810,000 | -20.4% | 250,000 | 0.0% | 0.27% | -10.9% |
Q4 2015 | $6,040,000 | -12.3% | 250,000 | -10.9% | 0.30% | -24.5% |
Q3 2015 | $6,888,000 | +51.2% | 280,700 | +44.3% | 0.40% | +61.9% |
Q2 2015 | $4,556,000 | +59.4% | 194,500 | +52.7% | 0.25% | +14.9% |
Q1 2015 | $2,858,000 | – | 127,400 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |